Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-2.41%
operating margin TTM
2.32%
revenue TTM
144.77 Million
revenue per share TTM
7.52$
valuation ratios | |
|---|---|
| pe ratio | -504.37 |
| peg ratio | 4.95 |
| price to book ratio | 2.45 |
| price to sales ratio | 12.35 |
| enterprise value multiple | -30.82 |
| price fair value | 2.45 |
profitability ratios | |
|---|---|
| gross profit margin | 77.53% |
| operating profit margin | 2.32% |
| pretax profit margin | 1.51% |
| net profit margin | -2.41% |
| return on assets | -0.43% |
| return on equity | -0.5% |
| return on capital employed | 0.43% |
liquidity ratio | |
|---|---|
| current ratio | 8.93 |
| quick ratio | 8.55 |
| cash ratio | 1.95 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 137.15 |
| operating cycle | 220.95 |
| days of payables outstanding | 50.85 |
| cash conversion cycle | 170.11 |
| receivables turnover | 4.36 |
| payables turnover | 7.18 |
| inventory turnover | 2.66 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.01 |
| total debt to capitalization | 0.01 |
| interest coverage | 1.28 |
| cash flow to debt ratio | 13.65 |
cash flow ratios | |
|---|---|
| free cash flow per share | 4.20 |
| cash per share | 13.50 |
| operating cash flow per share | 5.11 |
| free cash flow operating cash flow ratio | 0.82 |
| cash flow coverage ratios | 13.65 |
| short term coverage ratios | 75.15 |
| capital expenditure coverage ratio | 5.64 |
Frequently Asked Questions
When was the last time Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) reported earnings?
Ligand Pharmaceuticals Incorporated (LGND) published its most recent earnings results on 08-11-2024.
What is Ligand Pharmaceuticals Incorporated's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)'s trailing twelve months ROE is -0.5%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ligand Pharmaceuticals Incorporated (LGND) currently has a ROA of -0.43%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did LGND's net profit margin stand at?
LGND reported a profit margin of -2.41% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is LGND's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 8.93 in the most recent quarter. The quick ratio stood at 8.55, with a Debt/Eq ratio of 0.01.